Paysign (NASDAQ:PAYS) EVP Joan Herman Sells 21,004 Shares of Stock

Paysign, Inc. (NASDAQ:PAYS) EVP Joan Herman sold 21,004 shares of Paysign stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $12.38, for a total transaction of $260,029.52. Following the completion of the transaction, the executive vice president owned 648,321 shares of the company’s stock, valued at $8,026,213.98. This represents a 3.14% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Paysign Price Performance

NASDAQ:PAYS opened at $12.42 on Friday. Paysign, Inc. has a 1 year low of $3.08 and a 1 year high of $14.43. The stock’s fifty day moving average price is $11.46 and its two-hundred day moving average price is $8.01. The company has a market cap of $701.23 million, a P/E ratio of 47.77 and a beta of 0.80.

Paysign (NASDAQ:PAYS) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.05. The company had revenue of $28.25 million for the quarter, compared to analyst estimates of $26.36 million. Paysign had a return on equity of 30.13% and a net margin of 15.67%.Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. On average, analysts expect that Paysign, Inc. will post 0.58 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Wall Street Zen lowered shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Weiss Ratings upgraded shares of Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, July 29th. DA Davidson raised their price objective on shares of Paysign from $9.00 to $12.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Barrington Research set a $15.00 price objective on shares of Paysign in a report on Tuesday, August 11th. Finally, Lake Street Capital upped their target price on shares of Paysign from $13.00 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Paysign currently has a consensus rating of “Buy” and an average price target of $14.00.

Hedge Funds Weigh In On Paysign

Institutional investors and hedge funds have recently made changes to their positions in the business. Tidal Investments LLC purchased a new position in Paysign in the 2nd quarter worth $121,000. Connective Capital Management LLC bought a new stake in Paysign in the second quarter worth $327,000. Corient Private Wealth LP boosted its position in Paysign by 69.8% during the second quarter. Corient Private Wealth LP now owns 30,159 shares of the company’s stock valued at $247,000 after buying an additional 12,396 shares during the period. Punch & Associates Investment Management Inc. bought a new position in shares of Paysign during the second quarter valued at about $16,983,000. Finally, Bank of America Corp DE bought a new position in shares of Paysign during the second quarter valued at about $335,000. Institutional investors own 25.89% of the company’s stock.

Paysign Company Profile

Paysign, Inc is a financial technology company that provides payment and financial services primarily to the healthcare and pharmaceutical industries. Its platform supports prepaid card programs, digital payments and other disbursement solutions designed to help organizations distribute funds to individuals efficiently and securely.

The company’s services include patient assistance programs that help eligible patients receive financial support for prescription medications and other healthcare costs.